-
ENDRA Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results
Nov 13, 2019
Conference call scheduled for 4:30 p.m. ET today...read more > -
ENDRA Life Sciences to Host Third Quarter 2019 Financial Results Conference Call and Webcast on Wednesday, November 13, 2019 at 4:30 p.m. ET
Nov 5, 2019
ANN ARBOR, MI / ACCESSWIRE / November 5, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its third quarter fi...read more > -
ENDRA Life Sciences to Host Key Opinion Leader (KOL) Event in Conjunction with the Annual 2019 AASLD Liver Meeting
Nov 4, 2019
ANN ARBOR, MI / ACCESSWIRE / November 4, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that the company will ho...read more > -
ENDRA Life Sciences to present at H.C. Wainwright 3rd Annual NASH Investor Conference
Oct 14, 2019
ANN ARBOR, MI / ACCESSWIRE / October 14, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that company management w...read more > -
ENDRA Life Sciences Reports Completion and Top Level Findings of Second Phase of Robarts Research Institute Liver Fat Feasibility Study
Sep 26, 2019
ANN ARBOR, MI / ACCESSWIRE / September 26, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today reported that Robarts Research Institute has co...read more > -
ENDRA Life Sciences to Showcase TAEUS(TM) Liver Application at the EASL Non-Alcoholic Fatty Liver Disease Summit in Seville, Spain on September 26-28, 2019
Sep 10, 2019
ANN ARBOR, MICHIGAN / ACCESSWIRE / September 10, 2019 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), will attend the EASL Nonalcoh...read more > -
ENDRA Life Sciences to Participate at Upcoming Investor Conferences
Aug 21, 2019
ANN ARBOR, MI / ACCESSWIRE / August 21, 2019 / ENDRA Life Sciences Inc.(“ENDRA”) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that management will pa...read more > -
ENDRA Life Sciences Reports Second Quarter 2019 Financial & Operational Results
Aug 8, 2019
Management to Host Second Quarter 2019 Conference Call Today at 4:30 p.m. ET...read more > -
ENDRA Life Sciences Completes Private Placement of $2.8 Million of Convertible Secured Notes and Warrants
Jul 29, 2019
Raise Fortifies Balance Sheet ...read more > -
ENDRA Life Sciences to Host Second Quarter 2019 Results Conference Call on Thursday, August 8, 2019 at 4:30 p.m. ET
Jul 22, 2019
ANN ARBOR, MI / ACCESSWIRE / July 22, 2019 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ: NDRA), a developer of enhanced ultrasound technologies, will hold a conference call on Thursday, August 8, ...read more >
